FEMY

Femasys Inc

$4.17 -0.18 (-4.14%) At close · Jul 2

Market Cap

$251.83M

60,390,686

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-06-24	Femasys Regains Compliance with Nasdaq Listing Requirements
2026-05-13	Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
2026-05-08	Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
2026-05-05	Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
2026-04-22	Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
2026-04-16	Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
2026-04-01	Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
2026-03-31	Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
2026-03-18	Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
2026-03-10	Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

Past events

Date	Event	Type
2024-03-21	The Infertility Treatment Landscape	Event
2022-07-28	KOL Event on FemBloc	Event
2022-07-28	Femasys KOL Event	Event

Source: https://ir.femasys.com/

Key facts CIK 1339005 CUSIP 31447E105 13F (30d) 8 filings 2 filers Visit website Investor relations